• Abstract Molecules

    PredictImmune announces new strategic partnership to commercialise its PredictSURE IBD™ prognostic test for inflammatory bowel disease, across North America

  • Robotic

    Galaxy Care becomes first hospital in the world to acquire the Versius surgical robotic system

  • Dna Illustration

    Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test

  • Bicycle Technology

    Bicycle Therapeutics enters neuroscience arena through collaboration with Dementia Discovery Fund

  • Green Abstract Patterns

    Lord Prior opens CMR Surgical global headquarters

  • Bicycle Technology

    Bicycle Therapeutics and Oxurion announce full enrollment in Phase I trial

  • Dna Illustration

    Inivata, Thermo Fisher Scientific, and Genomics England successfully complete first phase of study assessing plasma samples and potential of liquid biopsy

  • Eye

    Gyroscope Therapeutics merges with Orbit Biomedical

  • Pragmatic New Wafer

    Following ConnectIC product launch, PragmatIC’s order-book already exceeds 20,000,000 units

  • Mobile Alert Message

    Audio Analytic granted new patent to give headphones a sense of hearing

  • Dna

    Congenica announces on-premise deployment option for its Sapientia platform

  • Digital Map Pins

    Pontus Noren to join GeoSpock’s Board as company secures further £2 million

  • Pragmatic New Wafer

    Mühlbauer and PragmatIC announce strategic partnership delivering innovative RFID manufacturing solutions

  • Dna Illustration

    Inivata publishes positive results of clinical study for InVision® liquid biopsy test

  • Digital Map Pins

    GeoSpock strikes commercial partnership with Smart Cambridge to further smart city ambitions

  • Dna Illustration

    Inivata receives final Medicare Coverage Determination of InVision-First-Lung

  • Bicycle Technology

    Bicycle Therapeutics to present on BT5528, a Bicycle-toxin conjugate targeting EphA2 for the treatment of solid tumours

  • Bicycle Technology

    Bicycle Therapeutics awarded SBRI contract to address antimicrobial resistance

  • Ingeborg Oie

    CMR Surgical appoints Ingeborg Øie as CFO

  • Morphogen

    Morphogen-IX announces MGX292 as clinical development candidate

  • Hauser Forum Building

    Fluidic Analytics raises $31 million

  • Bicycle Technology

    Bicycle Therapeutics named best new drug developer at 2018 World ADC awards

  • Pragmatic

    PragmatIC and S&S sign strategic collaboration for novel RFID solutions

  • Microbiotica

    Microbiotica attracts equity investment from Seventure

  • Giants Causeway

    Carrick Therapeutics in-licenses targeted ovarian cancer treatment from BTG and appoints George Golumbeski as Chairman

  • Dna Illustration

    Inivata presents results of prospective clinical validation study of its InVisionFirst-Lung liquid biopsy test

  • Origami Power Lines

    Origami Energy signs deal to connect and control 19MW of battery storage assets

  • Origami Power Lines

    SSE boosts its service offering with Origami Energy deal

  • Dna Illustration

    Inivata strengthens senior leadership team

  • Undo

    Undo appoints Barry Morris as CEO to lead growth phase

  • Dna

    Congenica appoints Wendy Britten as CFO

  • Hauser Forum Building

    GeoSpock and Tamoco partner to scale location data insights

  • Morphogen

    Morphogen-IX appoints CEO and forms global Scientific Advisory Board

  • Mobile Alert Message

    Audio Analytic named as a leading AI company in Disrupt 100 index

  • Cytora

    MS Amlin partners with Cytora to deploy AI underwriting

  • Microbiotica

    Microbiotica collaborates with University of Adelaide to develop a novel microbial therapy for ulcerative colitis

  • Cytora

    Cytora awarded ‘Best AI Product in Insurance’ at CogX Awards

  • Geospock Rocket

    GeoSpock welcomes new Chief Commercial Officer

  • Bicycle Technology

    Bicycle Therapeutics expands strategic partnership with AstraZeneca

  • Pragmatic

    PragmatIC reinvents electonics manufacturing for the mass market

  • Mobile Alert Message

    See no evil. Hear it.

  • Prowlerio Ai Platform

    PROWLER.io launches VUKU

  • Digital Map Pins

    GeoSpock launches unique location intelligence platform

  • Origami Power Lines

    Leading technology businesswoman Margaret Rice-Jones joins Origami Energy as Chairman

  • Bicycle Technology

    Bicycle Therapeutics to present new BT1718 data at 2018 AACR

  • Dna Illustration

    Inivata publishes results of analytical validation for InVisionFirst-Lung

  • Dna Illustration

    Inivata announces collaboration with MedStar Health

  • Table Star Lights

    Hive Hub 360 launched with Audio Analytic technology

  • Books

    Co-writing K-pop with artificial intelligence

  • Hauser Forum Building

    SmartestEnergy announces landmark deal with Origami Energy

  • Bicycle Technology

    Bicycle Therapeutics and CRUK announce initiation of first clinical study of a bicyclic peptide

  • Dna

    Congenica appoints new CEO

  • Mobile Alert Message

    Audio Analytic announces partnership with Hive

  • Green Abstract Patterns

    Cambridge Medical Robotics plans new Cambridge headquarters building

  • Storm Therapeutics

    Taiho invests in STORM Therapeutics

  • Bicycle Technology

    Bicycle Therapeutics awarded Innovate UK grant to develop novel antibiotics

  • Team Shot

    Awards for Cambridge Medical Robotics and Bicycle Therapeutics

  • Mobile Alert Message

    Audio Analytic and Bragi to add cloudless sound recognition to hearables

  • Origami Power Lines

    Good Energy partners with Origami Energy

  • Giants Causeway

    First patient dosed in Carrick Therapeutics' phase 1 clinical trial of CT7001

  • Storm Therapeutics

    Nature publication on RNA epigenetics by STORM Therapeutics founder Professor Tony Kouzarides

  • Geospock Rocket

    GeoSpock appoints technology entrepreneur Richard Baker as CEO

  • Exvastat Banner

    Exvastat begins clinical development programme for treatment of ARDS

  • Pragmatic Chip

    TALKIN' THINGS and PragmatIC announce strategic partnership to make trillions of products talk

  • Storm Therapeutics

    Professor Paul Workman joins the board of STORM Therapeutics

  • Dna Illustration

    Inivata announces strategic partnership with West Cancer Center

  • Bicycle Technology

    Bicycle Therapeutics to present mechanism of action of BT1718

  • Dna Illustration

    Inivata unveils SAB

  • Dna Illustration

    Inivata highlights new clinical data on InVision™ platform in advanced NSCLC

  • Dna Illustration

    Inivata and Genomics England to explore potential of liquid biopsy

  • Dna Illustration

    Addario Lung Cancer Medical Research Institute and Inivata announce major study

  • Bicycle Technology

    Bicycle Therapeutics appoints Maria Koehler as CMO

  • Dna Illustration

    Inivata appoints Dr Jamie Platt as COO

  • Dna Illustration

    Inivata announces strategic partnership with Levine Cancer Institute and formation of IKAN

  • Dna

    Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project

  • Bicycle Technology

    Bioverativ and Bicycle Therapeutics enter into strategic research collaboration

  • Giants Causeway

    Carrick Therapeutics appoints chairman as one of two new board members

  • Storm Therapeutics

    Evotec exapnds collaboration with Storm Therapeutics on its RNA epigenetics platform

  • Dna Illustration

    Inivata Highlights New Clinical Data on the InVision™ ctDNA Liquid Biopsy Platform in advanced NSCLC at ASCO 2017 Annual Meeting

  • Pragmatic Chip

    PragmatIC named Future Planet “Company of the Year”

  • Mobile Alert Message

    OK Rover! Now connect your dog to your smart home

  • Mobile Alert Message

    Audio Analytic moves into new HQ

  • Imagen Enterprise Video Platform

    Charlie Horrell joins Imagen as CEO

  • Microbiotica

    Microbiotica appoints Dr John Shields as a non-executive director

  • Pervasid

    PervasID launches Space Ranger 9200

  • Pragmatic

    PragmatIC to establish billion unit production capacity for flexible integrated circuits by 2018

  • Dna Illustration

    Undo continues to grow with Cambridge office move

  • Dna

    Completion of Series B for Congenica and Chinese commercial partnership

  • Dna

    Congenica and Edico Genome partnership

  • Origami Power Lines

    Origami Energy named startup to watch in 2017

  • Dna Illustration

    Inivata and Gustave Roussy publish first reported study of clinical outcomes in patients whose treatment was based on ctDNA profiling

  • Storm Therapeutics

    Storm Therapeutics appoints CEO and Chairman

  • Green Abstract Patterns

    CMR continues rapid expansion

  • Imagen Enterprise Video Platform

    Imagen releases Imagen 5

  • Undo

    SAP selects Undo's Live Recorder for SAP HANA platform

  • Green Abstract Patterns

    Patrick Pordage appointed head of marketing at CMR

  • Digital Map Pins

    Geospock selected for Upscale 2017

  • Dna

    Congenica expands in North America appointing Dr Shikha O'Brien as Chief Business Officer

  • Mobile Alert Message

    Audio Analytic Showcases Artificial Audio Intelligence for Smart Home Devices at CES 2017

  • Green Abstract Patterns

    CMR launches Versius robotic surgery system

  • Dna Illustration

    Inivata and Gustave Roussy to Present Data at World Lung Conference

  • Dna Illustration

    Inivata Wins One Nucleus BioNewsRound Award 2016 at Genesis Conference

  • Dna

    Elucigene partners with Congenica on new NGS cystic fibrosis kit

  • Imagen Enterprise Video Platform

    Imagen wins Cambridge Digital Award

  • Dna

    Prime Minister opens Congenica's new home in the business incubator building on the Wellcome Genome Campus

  • Imagen Enterprise Video Platform

    World Curling Federation choose Imagen to provide their video archive

  • Imagen Enterprise Video Platform

    Gateway Church choose Imagen for online subscription platform

  • Imagen Enterprise Video Platform

    Imagen becomes proud corporate partner for BBC Media Action

  • Pervasid (1)

    PervasID launches new RFID system

  • Dna Illustration

    Inivata and N-of-One to provide personalised genomic interpretation and clinical trial matching

  • Dna

    Congenica's Sapientia helps manage ten-fold increase in demand for genomic analysis

  • Dna Illustration

    Inivata launches clinical validation study in non-small cell lung cancer

  • Dna

    Congenica wins OBN award

  • Undo

    Undo's Live Recorder wins award

  • Mobile Alert Message

    Audio Analytic featured on Bloomberg TV

  • CIC Building Green Overlay

    Undo announces Live Recorder plugin for Jenkins community

  • CIC Building Green Overlay

    Inivata opens US CLIA laboratory

  • CIC Building Green Overlay

    Imagen wins IABM award

  • CIC Building Green Overlay

    Congenica first UK company to deliver diagnostic reports to 100,000 Genomes Project

  • Green Abstract Patterns

    CMR appoints Chairman

  • CIC Building Green Overlay

    Jukedeck wins an Innovation Lion at the Cannes Lions

  • CIC Building Green Overlay

    Patient capital allows time for growth

  • CIC Building Green Overlay

    Portfolio companies have success in business awards

  • CIC Building Green Overlay

    Turning disruption into production

  • CIC Building Green Overlay

    Venturefest East to hear from Cambridge Innovation Capital advisors

  • CIC Building Green Overlay

    Jukedeck: Working in harmony